Annette de Thurah

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

DOI

  • Victoria Furer, Tel Aviv Sourasky Medical Center, Tel Aviv University
  • ,
  • Christien Rondaan, University of Groningen
  • ,
  • Nancy Agmon-Levin, Tel Aviv University, Zabludowicz Center for Autoimmune Diseases
  • ,
  • Sander Van Assen, Treant Care Group
  • ,
  • Marc Bijl, Martini Ziekenhuis
  • ,
  • Meliha Crnkic Kapetanovic, Lund University
  • ,
  • Annette De Thurah
  • Ulf Mueller-Ladner, Justus Liebig University Giessen
  • ,
  • Daphna Paran, Tel Aviv Sourasky Medical Center, Tel Aviv University
  • ,
  • Karen Schreiber, Syddansk Universitet, King's College London, Saint Thomas' Hospitals
  • ,
  • Klaus Warnatz, University of Freiburg
  • ,
  • Nico M. Wulffraat, University Medical Center Utrecht
  • ,
  • Ori Elkayam, Tel Aviv Sourasky Medical Center, Tel Aviv University

In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.

OriginalsprogEngelsk
Artikelnummere001594
TidsskriftRMD Open
Vol/bind7
Nummer1
Antal sider10
DOI
StatusUdgivet - apr. 2021

Se relationer på Aarhus Universitet Citationsformater

ID: 220375942